Release date: 17 February 2004
Promoter – Financial Intermediary
Deutsche Apotheker- und Aerztebank eG, Düsseldorf.Location
Description
Projects of limited scale in the field of medical professions. The projects will include investments in medical practices (premises and medical equipment) of doctors, dentists and veterinarians as well as pharmacies, exclusively located in assisted areas (objective 1 or 2) within the EU, mainly in Germany.
Objectives
With an exclusive focus on the medical professions and a market share of more than 50%, Apobank plays a central role as financial intermediary in this segment, which, by its very nature, is traditionally dominated by small-scale private enterprises. Under current global loan operations, allocations to the increasingly important medical sector are still rare. The start of global loan operations with Apobank promises to significantly improve the reach of EIB support to this sector. Final beneficiaries are private and public sector promoters of any size and ownership, mostly independent doctors, dentists and pharmacists.
Comments
Health.
Sector(s)
Proposed EIB finance (Approximate amount)
Up to EUR 100 m.
Total cost (Approximate amount)
Approximately EUR 200m.
Environmental aspects
Within the framework of the global loan, the Borrower will be requested to ensure compliance of the sub-projects with EU directives, as may be appropriate.
Procurement
Within the framework of the global loan, the Borrower will be requested to ensure compliance of the sub-projects with EU directives, as may be appropriate.
Status
Signed - 9/08/2004